flavin-adenine-dinucleotide and Liver-Neoplasms

flavin-adenine-dinucleotide has been researched along with Liver-Neoplasms* in 9 studies

Reviews

2 review(s) available for flavin-adenine-dinucleotide and Liver-Neoplasms

ArticleYear
Riboflavin metabolism in cancer.
    Nutrition reviews, 1974, Volume: 32, Issue:10

    Topics: Adenosine Triphosphate; Animals; Azo Compounds; Carcinogens; Carcinoma, Hepatocellular; Flavin Mononucleotide; Flavin-Adenine Dinucleotide; Humans; Liver Neoplasms; Male; Neoplasm Transplantation; Neoplasms; Neoplasms, Experimental; Nucleotidyltransferases; Rats; Riboflavin; Riboflavin Deficiency

1974
4th FEBS Meeting's Plenary Lecture. The biosynthesis of deoxyribonucleotides.
    European journal of biochemistry, 1968, Volume: 3, Issue:3

    Topics: Binding Sites; Carcinoma, Hepatocellular; Centrifugation, Density Gradient; Chromatography, Gel; Escherichia coli; Flavin-Adenine Dinucleotide; Lactobacillus; Liver Neoplasms; NADP; Nucleotides; Oxidation-Reduction; Oxidoreductases; Protein Binding; Ribose; Sulfides; Tritium

1968

Other Studies

7 other study(ies) available for flavin-adenine-dinucleotide and Liver-Neoplasms

ArticleYear
A Pegylated Flavin Adenine Dinucleotide PEG Complex to Boost Immunogenic and Therapeutic Effects in a Liver Cancer Model.
    Nanotheranostics, 2021, Volume: 5, Issue:4

    Flavin adenine dinucleotide (FAD) is engaged in several metabolic diseases. Its main role is being a cofactor essential for the activity of many flavoproteins, which play a crucial role in electron transport pathways in living systems. The aim of this study was to apply a pegylated flavins formulation named FAD-PEG diacide complex as theranostic pathway in cancer therapy. For this purpose, a mouse liver cancer model induced by Hepa1-6 cells was used to evaluate the therapeutic efficacy of FAD (named NP1) and FAD-PEG diacide complex (named NP2). The cytokines were applied to screen the serum inflammatory factors, to establish the blood cell content of different groups of nude mice. The highlights follows that FAD formulations (NP1; NP2) significantly suppressed the tumor growth and reduced the tumor index without effects on the body weight of mice. Furthermore, NP2 significantly reduced the serum levels of cytokines IL-6, TNF-α and IL-12 (P70). The reported results provide the proof-of-concept for the synthesis of a smart adjuvant for liver cancer therapy and support their further development in the field of nanomedicine.

    Topics: Animals; Antioxidants; Body Weight; Cell Line, Tumor; Cytokines; Flavin-Adenine Dinucleotide; Liver; Liver Neoplasms; Male; Mice; Mice, Nude; Polyethylene Glycols

2021
Biogenesis of the covalently flavinylated mitochondrial enzyme dimethylglycine dehydrogenase.
    The Journal of biological chemistry, 1996, Apr-19, Volume: 271, Issue:16

    Rat dimethylglycine dehydrogenase (Me2GlyDH) was used as model protein to study the biogenesis of a covalently flavinylated mitochondrial enzyme. Here we show that: 1) enzymatically active holoenzyme correlated with trypsin resistance of the protein; 2) folding of the reticulocyte lysate-translated protein into the trypsin-resistant, holoenzyme form was a slow process that was stimulated by the presence of the flavin cofactor and was more efficient at 15 degrees C than at 30 degrees C; 3) the mitochondrial presequence reduced the extent but did not prevent holoenzyme formation; 4) covalent attachment of FAD to the Me2GlyDH apoenzyme proceeded spontaneously and did not require a mitochondrial protein factor; 5) in vitro only the precursor, but not the mature form, of the protein was imported into isolated rat liver mitochondria; in vivo, in stably transfected HepG2 cells, both the precursor and the mature form were imported into the organelle; 6) holoenzyme formation in the cytoplasm did not prevent the translocation of the proteins into the mitochondria in vivo; and 7) lack of vitamin B2 in the tissue culture medium resulted in a reduced recovery of the precursor and the mature form of Me2GlyDH from cell mitochondria, suggesting a decreased efficiency of mitochondrial protein import.

    Topics: Amino Acid Sequence; Animals; Base Sequence; Cell Line; Cloning, Molecular; Dimethylglycine Dehydrogenase; Flavin-Adenine Dinucleotide; Gene Expression; Hepatoblastoma; Humans; Kinetics; Liver Neoplasms; Methionine; Mitochondria, Liver; Mitochondrial Proteins; Molecular Sequence Data; Oligodeoxyribonucleotides; Oxidoreductases, N-Demethylating; Protein Biosynthesis; Protein Processing, Post-Translational; Rats; Recombinant Proteins; Sulfur Radioisotopes; Transfection; Tumor Cells, Cultured

1996
Effects of riboflavin deficiency upon concentrations of riboflavin, flavin mononucleotide, and flavin adenine dinucleotide in Novikoff hepatoma in rats.
    Cancer research, 1973, Volume: 33, Issue:11

    Topics: Animals; Carcinoma, Hepatocellular; Flavin Mononucleotide; Flavin-Adenine Dinucleotide; Liver; Liver Neoplasms; Male; Neoplasms, Experimental; Nucleotidyltransferases; Rats; Riboflavin; Riboflavin Deficiency

1973
[Studies on riboflavin tetrabutyrate (B2-But) and its effects on p-dimethylaminoazobenzene (DAB) induced hepatoma or degenerated liver of the rat; ESR spectra of the subfraction of lipoperoxide extracted from the liver and several enzyme activities of the
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1968, Apr-10, Volume: 57, Issue:4

    Topics: Animals; Aspartate Aminotransferases; Carcinoma, Hepatocellular; Chemical and Drug Induced Liver Injury; Electron Spin Resonance Spectroscopy; Flavin-Adenine Dinucleotide; Infrared Rays; Isoenzymes; L-Lactate Dehydrogenase; Lipoproteins; Liver; Liver Diseases; Liver Neoplasms; Mitomycins; Neoplasms, Experimental; p-Dimethylaminoazobenzene; Peroxides; Rats; Riboflavin

1968
Riboflavin metabolism in liver diseases. IV. Enzymatic splitting and synthesis of flavin adenine dinucleotide in the p-dimethylaminoazobenzene induced rat liver carcinoma tissue.
    Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association, 1966, Jun-28, Volume: 65, Issue:6

    Topics: Animals; Flavin-Adenine Dinucleotide; In Vitro Techniques; Liver Neoplasms; Neoplasms, Experimental; Rats; Riboflavin

1966
Riboflavin metabolism in liver diseases. V. Clinical studies on the enzymatic splitting of flavin adenine dinucleotide in serum.
    Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association, 1966, Jun-28, Volume: 65, Issue:6

    Topics: Adult; Female; Flavin-Adenine Dinucleotide; Humans; Liver Diseases; Liver Neoplasms; Male; Riboflavin

1966
[Action of hydrocortisone on the level of water-soluble flavins and on dimethylaminoazobenzene reductase activity in the normal liver cell and at the onset of its cancerization].
    Bulletin de la Societe de chimie biologique, 1965, Volume: 47, Issue:6

    Topics: Animals; Carcinogens; Flavin-Adenine Dinucleotide; Flavins; Hydrocortisone; Liver; Liver Neoplasms; Oxidoreductases; p-Dimethylaminoazobenzene; Rats

1965